返回 Agenda
S16 : How will Post-Marketing Safety Measures Change with the Revision of the Pharmaceuticals and Medical Devices Act?
Session Chair(s)
Mamoru Narukawa, PhD, RPh
Professor
Kitasato University, Japan
Speaker(s)
Takashi YASUKAWA
Ministry of Health, Labour and Welfare (MHLW), Japan
Director, Pharmaceutical Safety Division, Pharmaceutical Safety Bureau
Makoto Miyazaki, PhD
Pharmacovigilance Expert Committee, Drug Evaluation Committee, JPMA, Japan
Chairperson
Susumu Wakabayashi
Kyorin University Hospital, Japan
Department of Pharmacy